Kwality Pharmaceuticals

Kwality Pharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of Kwality Pharmaceuticals (539997.BO) as of Nov 5, 2026 is 16.77 %. In the previous year, EBIT Margin (Operating Margin) was 15.23 % — a change of 10.12% (higher).

EBIT Margin

16.77 %

YoY

10.12%

Last updated:

EBIT Margin (Operating Margin) of Kwality Pharmaceuticals is 2025 16.77 % . EBIT Margin (Operating Margin) of Kwality Pharmaceuticals was 2024 15.23 % . It decreases by 10.12% higher compared to the previous year.

For Kwality Pharmaceuticals, the operating (EBIT) margin of 16.8% is up versus 8.5% a few years ago.

The Kwality Pharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
6.31 INR
Jan 1, 2019
7.57 INR
Jan 1, 2020
7.00 INR
Jan 1, 2021
8.53 INR
Jan 1, 2022
35.29 INR
Jan 1, 2023
18.00 INR
Jan 1, 2024
15.23 INR
Jan 1, 2025
16.77 INR
The Kwality Pharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
16.77 %+10.12%
15.23 %-15.37%
18.00 %-48.99%
35.29 %+313.57%
8.53 %+21.82%
7.00 %-7.47%
7.57 %+19.91%
6.31 %-1.75%
6.43 %+29.95%
4.94 %+32.51%
3.73 %-4.56%
3.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kwality Pharmaceuticals Stock analysis

What does Kwality Pharmaceuticals do? Kwality Pharmaceuticals Pvt Ltd manufactures pharmaceutical formulations including liquid orals, powders for oral suspension, tablets, capsules, sterile injections, ointments, and oral rehydration solutions. The company produces drugs in categories such as beta lactam, hormones, cytotoxic oncology, and effervescent. It handles customized business as per client requirements and has 48 production sections across its facilities. Kwality exports its products to Europe, Africa, and Asia, with registered products in these regions. The company operates as a manufacturer, buyer, and seller of pharmaceutical intermediates, chemicals, extracts, alkaloids, and medical preparations. It deals in drug intermediates, chemicals, and other pharmaceutical goods alongside toilet requisites and beverages. Kwality's business model focuses on exporting formulations to international markets, particularly targeting regions where its registered products are approved for sale. Kwality Pharmaceuticals serves as a manufacturer and distributor for pharmaceutical products, catering to global markets through its registered product portfolio. The firm's production capabilities include sterile powders for injections, small volume injectables, and external preparations, supporting diverse medical needs across different regions. Kwality Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kwality Pharmaceuticals stock

EBIT Margin (Operating Margin) of Kwality Pharmaceuticals is 16.77 % in 2025.

EBIT Margin (Operating Margin) of Kwality Pharmaceuticals changed from 15.23 % to 16.77 %, representing a 10.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Kwality Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Kwality Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Kwality Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Kwality Pharmaceuticals